Knocking down of RRM2 significantly decreased proliferation during S phase of cell cycle [6, 7] and induced tamoxifen resistance in breast cancer by regulating cell growth and DNA damage via the (AKT)-induced protein kinase B reversal [8]. The gene discussed is AKT1; the disease is breast cancer.